title: Clinical remission of Merkel cell carcinoma after treatment with imatinib.
authors.affiliation: Department of Dermatology and Venerology, Hietzing Municipal Hospital Vienna, Vienna, Austria. Electronic address: dagmara.loader@wienkav.at.
authors.forename: Dagmara Ewa
authors.initials: DE
authors.lastname: Loader
authors.forename: Robert
authors.initials: R
authors.lastname: Feldmann
authors.forename: Magdalena
authors.initials: M
authors.lastname: Baumgartner
authors.forename: Friedrich
authors.initials: F
authors.lastname: Breier
authors.forename: David
authors.initials: D
authors.lastname: Schrama
authors.forename: Jürgen Christian
authors.initials: JC
authors.lastname: Becker
authors.forename: Andreas
authors.initials: A
authors.lastname: Steiner
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D001707:Biopsy, Needle; D015266:Carcinoma, Merkel Cell / Q000175:diagnosis / Q000188:drug therapy*; D002610:Cheek; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging / Q000379:methods; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D040521:Subcutaneous Tissue / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate